ArticleClinical cancer research : an official journal of the American Association for Cancer Research2014

Canonical androstenedione reduction is the predominant source of signaling androgens in hormone-refractory prostate cancer.

Matthew Fankhauser et al.PubMed ↗Publisher ↗

No numbers read from the abstract.